Thermoreversible Gel Formulation for the Intranasal Delivery of Salmon Calcitonin and Comparison Studies of In Vivo Bioavailability
Turkish Journal of Pharmaceutical Sciences · 01.06.2023 · 20 (3) · 127-140
DOI: 10.4274/tjps.galenos.2022.09482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Pharmaceutical Sciences, online erschienen am 01.06.2023. Verfasst von Abdullah Levent Alparslan und 3 weiteren Autor:innen. Beteiligte Einrichtung: İstinye University, Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Türkiye. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
We developed original thermoreversible (sol-gel) formulations of salmon calcitonin (sCT) for nasal applications. The sol-gel has been compared with commercial intranasal sprays in vitro and in vivo studies. The aim of studying sol-gel form is to arrange the viscosity of formulations for a reversible adequate fluidity at different temperatures. This situation may facilitate the use of drugs as sprays and increase the bioadhesive ability to mucosa. Materials and Methods: Characterization of optimum formulations was studied. Validated analytical assays determined the number of sCT. An approximately equal number of commercial and sol-gel dosages were sprayed into the nostrils of the rabbits. Blood samples were collected from the ear veins of rabbits and determined by enzyme immunoassay plates. These plates were evaluated by Thermo Labsystem Multiscan Spectrum at 450 nm. Thanks to Winnonlin 5.2, pharmacokinetic data were evaluated by a non-compartmental method.
Results
The absolute bioavailability of the formulation at pH 4 and the commercial product (CP) was compared by evaluating the primary pharmacokinetic data area under the curve 0→tlast. The absolute bioavailability of the commercial intranasal spray was measured 1.88 based on maximum concentration (Cmax) assessment. Cmax of the sol-gel formulation pH 4 was calculated as 0.99 and the relative bioavailability was obtained 53.3%.
Conclusion
In vivo pharmacokinetic data of sol-gel formulation with pH 3 showed significantly higher volume of distribution parameter than the CP (111167>35408). It is thought that the formulation adhered to the nasal mucosa releases sCT slowly and less.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- İstinye University, Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Türkiye.
- Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology, İzmir, Türkiye.
- Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Medical Biochemistry, Ankara, Türkiye.
ORCID-Profile: Abdullah Levent Alparslan, Gülbeyaz Yıldız Türkyılmaz, Leyla Didem Kozacı, Ercüment Karasulu
Zitieren
APA
Alparslan, A. L., Yıldız Türkyılmaz, G., Kozacı, L. D., & Karasulu, E. (2023). Thermoreversible Gel Formulation for the Intranasal Delivery of Salmon Calcitonin and Comparison Studies of In Vivo Bioavailability. Turkish Journal of Pharmaceutical Sciences, 20(3), 127-140. https://doi.org/10.4274/tjps.galenos.2022.09482
Vancouver
Alparslan AL, Yıldız Türkyılmaz G, Kozacı LD, Karasulu E. Thermoreversible Gel Formulation for the Intranasal Delivery of Salmon Calcitonin and Comparison Studies of In Vivo Bioavailability. Turkish Journal of Pharmaceutical Sciences. 2023;20(3):127-140. doi:10.4274/tjps.galenos.2022.09482
BibTeX
@article{Alparslan2023,
author = {Alparslan, Abdullah Levent and Yıldız Türkyılmaz, Gülbeyaz and Kozacı, Leyla Didem and Karasulu, Ercüment},
title = {Thermoreversible Gel Formulation for the Intranasal Delivery of Salmon Calcitonin and Comparison Studies of In Vivo Bioavailability},
journal = {Turkish Journal of Pharmaceutical Sciences},
year = {2023},
volume = {20},
number = {3},
pages = {127--140},
doi = {10.4274/tjps.galenos.2022.09482}
}
EUVIMED